• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Sandoz launches SYMJEPI in the US americanpharmaceuticalreview
    January 21, 2019
    Sandoz announced the US market introduction of SYMJEPI (epinephrine) 0.3 mg Injection for the emergency treatment of allergic reactions (Type 1), including anaphylaxis.....
  • Sandoz Announces FDA Approval of Pediatric Dose of Symjepi americanpharmaceuticalreview
    September 29, 2018
    Sandoz announced the US Food and Drug Administration (FDA) has approved Symjepi (epinephrine) 0.15 mg Injection for the emergency treatment of allergic reactions in children.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service